APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sex Hormones

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Sex Hormones Market Outlook and Growth Opportunities 2026

22 December 2025199 pages

Choose your research edition.

Industry ResearchSex Hormones Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Sex Hormones Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Sex Hormones Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sex Hormones Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Sex Hormones Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Sex Hormones market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Sex Hormones is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sex Hormones is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sex Hormones is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Sex Hormones market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Sex Hormones market include Zizhu Pharma, Sanofi, Novartis, Merck, Pfizer, GSK, Bayer, AstraZeneca and Cipla, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sex Hormones market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sex Hormones and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sex Hormones sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sex Hormones market size, projected growth trends, production technologies, key applications, and end-use industries.

Sex Hormones Segment by Company

Zizhu Pharma

Sanofi

Novartis

Merck

Pfizer

GSK

Bayer

AstraZeneca

Cipla

Sex Hormones Segment by Type

Drospirenone

Progesterone

Testosterone

Others

Sex Hormones Segment by Application

Injection

Inhalation

Oral

Topical

Sex Hormones Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Sex Hormones status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Sex Hormones market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sex Hormones significant trends, drivers, influence factors in global and regions.

6. To analyze Sex Hormones competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sex Hormones market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sex Hormones and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sex Hormones.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sex Hormones market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sex Hormones industry.

Chapter 3: Detailed analysis of Sex Hormones manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Sex Hormones in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Sex Hormones in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sex Hormones Industry Trends Table 2. Sex Hormones Industry Drivers Table 3. Sex Hormones Industry Opportunities and Challenges Table 4. Sex Hormones Industry Restraints Table 5. Global Sex Hormones Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sex Hormones Revenue Share by Company (2021-2026) Table 7. Global Sex Hormones Sales Volume by Company (k units) & (2021-2026) Table 8. Global Sex Hormones Sales Volume Share by Company (2021-2026) Table 9. Global Sex Hormones Average Price (US$/unit) of Company (2021-2026) Table 10. Global Sex Hormones Company Ranking, (2024-2026) & (USD Million) Table 11. Global Sex Hormones Key Company Manufacturing Base & Headquarters Table 12. Global Sex Hormones Company, Product Type & Application Table 13. Global Sex Hormones Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Sex Hormones by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Drospirenone Table 18. Significant Companies of Progesterone Table 19. Significant Companies of Testosterone Table 20. Significant Companies of Others Table 21. Global Sex Hormones Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Sex Hormones Sales Volume by Type (2021-2026) & (k units) Table 23. Global Sex Hormones Sales Volume by Type (2027-2032) & (k units) Table 24. Global Sex Hormones Sales Volume Share by Type (2021-2026) Table 25. Global Sex Hormones Sales Volume Share by Type (2027-2032) Table 26. Global Sex Hormones Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Sex Hormones Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Sex Hormones Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Sex Hormones Sales Value Share by Type (2021-2026) Table 30. Global Sex Hormones Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Injection Table 32. Significant Companies of Inhalation Table 33. Significant Companies of Oral Table 34. Significant Companies of Topical Table 35. Global Sex Hormones Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Sex Hormones Sales Volume by Application (2021-2026) & (k units) Table 37. Global Sex Hormones Sales Volume by Application (2027-2032) & (k units) Table 38. Global Sex Hormones Sales Volume Share by Application (2021-2026) Table 39. Global Sex Hormones Sales Volume Share by Application (2027-2032) Table 40. Global Sex Hormones Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Sex Hormones Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Sex Hormones Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Sex Hormones Sales Value Share by Application (2021-2026) Table 44. Global Sex Hormones Sales Value Share by Application (2027-2032) Table 45. Global Sex Hormones Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Sex Hormones Sales by Region (2021-2026) & (k units) Table 47. Global Sex Hormones Sales Market Share by Region (2021-2026) Table 48. Global Sex Hormones Sales by Region (2027-2032) & (k units) Table 49. Global Sex Hormones Sales Market Share by Region (2027-2032) Table 50. Global Sex Hormones Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Sex Hormones Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Sex Hormones Sales Value Share by Region (2021-2026) Table 53. Global Sex Hormones Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Sex Hormones Sales Value Share by Region (2027-2032) Table 55. Global Sex Hormones Market Average Price (US$/unit) by Region (2021-2026) Table 56. Global Sex Hormones Market Average Price (US$/unit) by Region (2027-2032) Table 57. Global Sex Hormones Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global Sex Hormones Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Sex Hormones Sales by Country (2021-2026) & (k units) Table 60. Global Sex Hormones Sales Market Share by Country (2021-2026) Table 61. Global Sex Hormones Sales by Country (2027-2032) & (k units) Table 62. Global Sex Hormones Sales Market Share by Country (2027-2032) Table 63. Global Sex Hormones Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Sex Hormones Sales Value Market Share by Country (2021-2026) Table 65. Global Sex Hormones Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Sex Hormones Sales Value Market Share by Country (2027-2032) Table 67. Zizhu Pharma Company Information Table 68. Zizhu Pharma Business Overview Table 69. Zizhu Pharma Sex Hormones Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Zizhu Pharma Sex Hormones Product Portfolio Table 71. Zizhu Pharma Recent Development Table 72. Sanofi Company Information Table 73. Sanofi Business Overview Table 74. Sanofi Sex Hormones Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Sanofi Sex Hormones Product Portfolio Table 76. Sanofi Recent Development Table 77. Novartis Company Information Table 78. Novartis Business Overview Table 79. Novartis Sex Hormones Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Novartis Sex Hormones Product Portfolio Table 81. Novartis Recent Development Table 82. Merck Company Information Table 83. Merck Business Overview Table 84. Merck Sex Hormones Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Merck Sex Hormones Product Portfolio Table 86. Merck Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Sex Hormones Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Pfizer Sex Hormones Product Portfolio Table 91. Pfizer Recent Development Table 92. GSK Company Information Table 93. GSK Business Overview Table 94. GSK Sex Hormones Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. GSK Sex Hormones Product Portfolio Table 96. GSK Recent Development Table 97. Bayer Company Information Table 98. Bayer Business Overview Table 99. Bayer Sex Hormones Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Bayer Sex Hormones Product Portfolio Table 101. Bayer Recent Development Table 102. AstraZeneca Company Information Table 103. AstraZeneca Business Overview Table 104. AstraZeneca Sex Hormones Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. AstraZeneca Sex Hormones Product Portfolio Table 106. AstraZeneca Recent Development Table 107. Cipla Company Information Table 108. Cipla Business Overview Table 109. Cipla Sex Hormones Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Cipla Sex Hormones Product Portfolio Table 111. Cipla Recent Development Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Sex Hormones Distributors List Table 115. Sex Hormones Customers List Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Sex Hormones Product Image Figure 2. Global Sex Hormones Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sex Hormones Sales Value (2021-2032) & (US$ Million) Figure 4. Global Sex Hormones Sales (2021-2032) & (k units) Figure 5. Global Sex Hormones Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Sex Hormones Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Drospirenone Image Figure 10. Progesterone Image Figure 11. Testosterone Image Figure 12. Others Image Figure 13. Global Sex Hormones Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Sex Hormones Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Sex Hormones Sales Volume Share by Type (2021-2032) Figure 16. Global Sex Hormones Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Sex Hormones Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Sex Hormones Sales Value Share by Type (2021-2032) Figure 19. Injection Image Figure 20. Inhalation Image Figure 21. Oral Image Figure 22. Topical Image Figure 23. Global Sex Hormones Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Sex Hormones Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Sex Hormones Sales Volume Share by Application (2021-2032) Figure 26. Global Sex Hormones Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Sex Hormones Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Sex Hormones Sales Value Share by Application (2021-2032) Figure 29. Global Sex Hormones Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global Sex Hormones Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Sex Hormones Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Sex Hormones Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Sex Hormones Sales Value (2021-2032) & (US$ Million) Figure 34. North America Sex Hormones Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Sex Hormones Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Sex Hormones Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Sex Hormones Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Sex Hormones Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Sex Hormones Sales Value (2021-2032) & (US$ Million) Figure 40. South America Sex Hormones Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Sex Hormones Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Sex Hormones Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Sex Hormones Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Sex Hormones Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Sex Hormones Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Sex Hormones Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Sex Hormones Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Drospirenone
  • Progesterone
  • Testosterone
  • Others
Applications
  • Injection
  • Inhalation
  • Oral
  • Topical
Companies covered
  • Zizhu Pharma
  • Sanofi
  • Novartis
  • Merck
  • Pfizer
  • GSK
  • Bayer
  • AstraZeneca
  • Cipla

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sex Hormones Sales Value (2021-2032)
  4. 1.2.2 Global Sex Hormones Sales Volume (2021-2032)
  5. 1.2.3 Global Sex Hormones Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Sex Hormones Market Dynamics
  1. 2.1 Sex Hormones Industry Trends
  2. 2.2 Sex Hormones Industry Drivers
  3. 2.3 Sex Hormones Industry Opportunities and Challenges
  4. 2.4 Sex Hormones Industry Restraints
3 Sex Hormones Market by Company
  1. 3.1 Global Sex Hormones Company Revenue Ranking in 2025
  2. 3.2 Global Sex Hormones Revenue by Company (2021-2026)
  3. 3.3 Global Sex Hormones Sales Volume by Company (2021-2026)
  4. 3.4 Global Sex Hormones Average Price by Company (2021-2026)
  5. 3.5 Global Sex Hormones Company Ranking (2024-2026)
  6. 3.6 Global Sex Hormones Company Manufacturing Base and Headquarters
  7. 3.7 Global Sex Hormones Company Product Type and Application
  8. 3.8 Global Sex Hormones Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Sex Hormones Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Sex Hormones Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Sex Hormones Market by Type
  1. 4.1 Sex Hormones Type Introduction
  2. 4.1.1 Drospirenone
  3. 4.1.2 Progesterone
  4. 4.1.3 Testosterone
  5. 4.1.4 Others
  6. 4.2 Global Sex Hormones Sales Volume by Type
  7. 4.2.1 Global Sex Hormones Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Sex Hormones Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Sex Hormones Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Sex Hormones Sales Value by Type
  11. 4.3.1 Global Sex Hormones Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Sex Hormones Sales Value by Type (2021-2032)
  13. 4.3.3 Global Sex Hormones Sales Value Share by Type (2021-2032)
5 Sex Hormones Market by Application
  1. 5.1 Sex Hormones Application Introduction
  2. 5.1.1 Injection
  3. 5.1.2 Inhalation
  4. 5.1.3 Oral
  5. 5.1.4 Topical
  6. 5.2 Global Sex Hormones Sales Volume by Application
  7. 5.2.1 Global Sex Hormones Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Sex Hormones Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Sex Hormones Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Sex Hormones Sales Value by Application
  11. 5.3.1 Global Sex Hormones Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Sex Hormones Sales Value by Application (2021-2032)
  13. 5.3.3 Global Sex Hormones Sales Value Share by Application (2021-2032)
6 Sex Hormones Regional Sales and Value Analysis
  1. 6.1 Global Sex Hormones Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sex Hormones Sales by Region (2021-2032)
  3. 6.2.1 Global Sex Hormones Sales by Region: 2021-2026
  4. 6.2.2 Global Sex Hormones Sales by Region (2027-2032)
  5. 6.3 Global Sex Hormones Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Sex Hormones Sales Value by Region (2021-2032)
  7. 6.4.1 Global Sex Hormones Sales Value by Region: 2021-2026
  8. 6.4.2 Global Sex Hormones Sales Value by Region (2027-2032)
  9. 6.5 Global Sex Hormones Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Sex Hormones Sales Value (2021-2032)
  12. 6.6.2 North America Sex Hormones Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Sex Hormones Sales Value (2021-2032)
  15. 6.7.2 Europe Sex Hormones Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Sex Hormones Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Sex Hormones Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Sex Hormones Sales Value (2021-2032)
  21. 6.9.2 South America Sex Hormones Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Sex Hormones Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Sex Hormones Sales Value Share by Country, 2025 VS 2032
7 Sex Hormones Country-level Sales and Value Analysis
  1. 7.1 Global Sex Hormones Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sex Hormones Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Sex Hormones Sales by Country (2021-2032)
  4. 7.3.1 Global Sex Hormones Sales by Country (2021-2026)
  5. 7.3.2 Global Sex Hormones Sales by Country (2027-2032)
  6. 7.4 Global Sex Hormones Sales Value by Country (2021-2032)
  7. 7.4.1 Global Sex Hormones Sales Value by Country (2021-2026)
  8. 7.4.2 Global Sex Hormones Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Sex Hormones Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Sex Hormones Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Sex Hormones Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Sex Hormones Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Sex Hormones Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Sex Hormones Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Sex Hormones Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Sex Hormones Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Sex Hormones Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Sex Hormones Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Sex Hormones Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Sex Hormones Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Sex Hormones Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Sex Hormones Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Sex Hormones Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Sex Hormones Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Sex Hormones Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Sex Hormones Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Sex Hormones Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Sex Hormones Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Sex Hormones Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Sex Hormones Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Sex Hormones Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Sex Hormones Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Sex Hormones Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Sex Hormones Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Sex Hormones Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Sex Hormones Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Sex Hormones Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Sex Hormones Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Sex Hormones Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Sex Hormones Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Sex Hormones Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Sex Hormones Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Sex Hormones Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Sex Hormones Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Sex Hormones Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Sex Hormones Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Sex Hormones Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Sex Hormones Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Sex Hormones Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Sex Hormones Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Sex Hormones Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Sex Hormones Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Sex Hormones Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Sex Hormones Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Sex Hormones Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Sex Hormones Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Sex Hormones Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Sex Hormones Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Sex Hormones Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Sex Hormones Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Sex Hormones Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Sex Hormones Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Sex Hormones Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Sex Hormones Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Sex Hormones Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Sex Hormones Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Sex Hormones Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Sex Hormones Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Sex Hormones Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Sex Hormones Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Sex Hormones Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Sex Hormones Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Sex Hormones Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Sex Hormones Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Sex Hormones Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Sex Hormones Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Sex Hormones Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Sex Hormones Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Sex Hormones Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Sex Hormones Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Sex Hormones Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Sex Hormones Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Sex Hormones Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Sex Hormones Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Sex Hormones Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Sex Hormones Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Sex Hormones Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Sex Hormones Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Sex Hormones Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Sex Hormones Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Sex Hormones Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Sex Hormones Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zizhu Pharma
  2. 8.1.1 Zizhu Pharma Company Information
  3. 8.1.2 Zizhu Pharma Business Overview
  4. 8.1.3 Zizhu Pharma Sex Hormones Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zizhu Pharma Sex Hormones Product Portfolio
  6. 8.1.5 Zizhu Pharma Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Sex Hormones Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Sex Hormones Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Sex Hormones Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Sex Hormones Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Sex Hormones Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Merck Sex Hormones Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Sex Hormones Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Sex Hormones Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 GSK
  32. 8.6.1 GSK Company Information
  33. 8.6.2 GSK Business Overview
  34. 8.6.3 GSK Sex Hormones Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 GSK Sex Hormones Product Portfolio
  36. 8.6.5 GSK Recent Developments
  37. 8.7 Bayer
  38. 8.7.1 Bayer Company Information
  39. 8.7.2 Bayer Business Overview
  40. 8.7.3 Bayer Sex Hormones Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Bayer Sex Hormones Product Portfolio
  42. 8.7.5 Bayer Recent Developments
  43. 8.8 AstraZeneca
  44. 8.8.1 AstraZeneca Company Information
  45. 8.8.2 AstraZeneca Business Overview
  46. 8.8.3 AstraZeneca Sex Hormones Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 AstraZeneca Sex Hormones Product Portfolio
  48. 8.8.5 AstraZeneca Recent Developments
  49. 8.9 Cipla
  50. 8.9.1 Cipla Company Information
  51. 8.9.2 Cipla Business Overview
  52. 8.9.3 Cipla Sex Hormones Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Cipla Sex Hormones Product Portfolio
  54. 8.9.5 Cipla Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sex Hormones Value Chain Analysis
  2. 9.1.1 Sex Hormones Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sex Hormones Sales Mode & Process
  6. 9.2 Sex Hormones Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sex Hormones Distributors
  9. 9.2.3 Sex Hormones Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst